NovoCure (NVCR) Institutional Ownership

$17.82 -0.17 (-0.94%)

As of 08/28/2026 04:00 PM Eastern

Current Institutional Ownership Percentage: 84.61%
Number of Institutional Buyers (last 12 months): 112
Total Institutional Inflows (last 12 months): $268.34M

Number of Institutional Sellers (last 12 months): 67
Total Institutional Outflows (last 12 months): $1.37B

Get NVCR Insider Trade Alerts

Want to know when executives and insiders are buying or selling NovoCure stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NVCR Institutional Buying and Selling by Quarter

NovoCure Major Shareholders & Ownership History

Export

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/27/2026	Corient Private Wealth LP	61,650	$934K	0.0%	-71.5%	0.053%
8/24/2026	California State Teachers Retirement System	1,774,004	$26.88M	0.0%	+1,144.4%	1.523%
8/22/2026	Syon Capital LLC	20,237	$307K	0.0%	-6.5%	0.017%
8/21/2026	Coppell Advisory Solutions LLC	38,953	$590K	0.1%	N/A	0.033%
8/20/2026	Proficio Capital Partners LLC	10,691	$162K	0.0%	N/A	0.009%
8/15/2026	First Bancorp Inc ME	2,500	$38K	0.0%	N/A	0.002%
7/10/2026	Handelsbanken Fonder AB	51,223	$776K	0.0%	+37.2%	0.044%
7/2/2026	Versant Capital Management Inc	12,093	$183K	0.0%	-20.8%	0.010%
5/19/2026	Bank of America Corp DE	170,013	$1.85M	0.0%	-50.4%	0.147%
5/18/2026	Amundi	47,583	$519K	0.0%	+19.9%	0.041%
Get the Latest News and Ratings for NVCR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NovoCure and its competitors with MarketBeat's FREE daily newsletter.
5/18/2026	California State Teachers Retirement System	142,561	$1.55M	0.0%	+43.6%	0.123%
5/18/2026	Royal Bank of Canada	9,211	$100K	0.0%	-28.2%	0.008%
5/18/2026	Eversept Partners LP	134,917	$1.47M	0.1%	+11.5%	0.116%
5/16/2026	The Manufacturers Life Insurance Company	39,598	$432K	0.0%	-4.1%	0.034%
5/16/2026	Quantinno Capital Management LP	2,487,376	$27.11M	0.0%	+23.7%	2.148%
5/14/2026	Healthcare of Ontario Pension Plan Trust Fund	726,400	$7.92M	0.0%	-21.7%	0.627%
5/14/2026	Renaissance Technologies LLC	1,551,554	$16.91M	0.0%	+11.8%	1.340%
5/14/2026	Arrowstreet Capital Limited Partnership	28,130	$307K	0.0%	N/A	0.024%
5/14/2026	Sei Investments Co.	114,281	$1.25M	0.0%	+367.6%	0.099%
5/13/2026	First Trust Advisors LP	94,293	$1.03M	0.0%	N/A	0.081%
5/7/2026	Dimensional Fund Advisors LP	960,056	$10.46M	0.0%	+27.6%	0.829%
5/6/2026	Kera Capital Partners Inc.	21,454	$234K	0.0%	+9.0%	0.019%
5/5/2026	Bank of New York Mellon Corp	281,471	$3.07M	0.0%	-5.7%	0.243%
5/5/2026	Hillsdale Investment Management Inc.	121,800	$1.33M	0.0%	-7.6%	0.105%
5/4/2026	Calamos Wealth Management LLC	24,954	$272K	0.0%	N/A	0.022%
5/4/2026	Calamos Advisors LLC	24,954	$272K	0.0%	N/A	0.022%
5/4/2026	Empirical Financial Services LLC d.b.a. Empirical Wealth Management	18,140	$198K	0.0%	N/A	0.016%
5/4/2026	Chicago Partners Investment Group LLC	20,101	$219K	0.0%	-17.7%	0.017%
4/30/2026	Hsbc Holdings PLC	31,690	$342K	0.0%	-32.3%	0.027%
4/27/2026	Counterpoint Mutual Funds LLC	49,382	$538K	0.1%	+27.9%	0.043%
4/27/2026	Y Intercept Hong Kong Ltd	127,780	$1.39M	0.0%	-16.8%	0.110%
4/25/2026	Strs Ohio	59,400	$647K	0.0%	+2.2%	0.051%
4/22/2026	Pictet Asset Management Holding SA	19,845	$216K	0.0%	+23.8%	0.017%
4/22/2026	Venturi Wealth Management LLC	11,266	$123K	0.0%	N/A	0.010%
4/16/2026	SG Americas Securities LLC	1,245,541	$13.58M	0.0%	+346.7%	1.095%
3/20/2026	Hsbc Holdings PLC	46,781	$614K	0.0%	-15.0%	0.041%
3/9/2026	Corient Private Wealth LLC	46,952	$608K	0.0%	+34.0%	0.041%
2/23/2026	Kera Capital Partners Inc.	19,691	$244K	0.0%	+84.4%	0.018%
2/19/2026	T. Rowe Price Investment Management Inc.	3,143	$41K	0.0%	-99.7%	0.003%
2/19/2026	Invesco Ltd.	67,968	$879K	0.0%	-10.3%	0.061%
The retirement stock I'd buy before Nvidia today (Ad) In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Chaikin Money Flow indicator has a new top retirement pick. The company holds three fast-growing businesses -- including an autonomous vehicle unit and a streaming service with 10x Netflix's reach -- any of which could be spun off in the next 12 to 24 months. It also pays a dividend, a rarity among high-growth AI names. Chaikin lays out the full case in a new free presentation, no email or credit card required. Get Marc Chaikin's free presentation on this overlooked AI stock now
2/19/2026	Corient Private Wealth LLC	97,368	$1.26M	0.0%	+178.0%	0.087%
2/18/2026	Mercer Global Advisors Inc. ADV	32,660	$422K	0.0%	+14.5%	0.029%
2/18/2026	Empowered Funds LLC	2,559	$33K	0.0%	N/A	0.002%
2/18/2026	XTX Topco Ltd	58,795	$760K	0.0%	+159.2%	0.053%
2/18/2026	Voloridge Investment Management LLC	407,204	$5.27M	0.0%	-35.5%	0.364%
2/18/2026	Vestal Point Capital LP	525,000	$6.79M	0.2%	+31.3%	0.469%
2/18/2026	Susquehanna Portfolio Strategies LLC	289,359	$3.74M	0.1%	+981.7%	0.258%
2/18/2026	Tudor Investment Corp ET AL	284,645	$3.68M	0.0%	-53.0%	0.254%
2/18/2026	Twinbeech Capital LP	11,330	$146K	0.0%	N/A	0.010%
2/18/2026	Polymer Capital Management US LLC	13,625	$176K	0.0%	N/A	0.012%
2/18/2026	Numerai GP LLC	51,218	$662K	0.1%	N/A	0.046%
2/18/2026	Millennium Management LLC	646,666	$8.36M	0.0%	-51.6%	0.577%
2/18/2026	Engineers Gate Manager LP	291,332	$3.77M	0.0%	+6.6%	0.260%
2/18/2026	Eversept Partners LP	120,978	$1.56M	0.1%	N/A	0.108%
2/18/2026	Balyasny Asset Management L.P.	31,339	$405K	0.0%	N/A	0.028%
2/18/2026	Boothbay Fund Management LLC	50,542	$654K	0.0%	N/A	0.045%
2/17/2026	ADAR1 Capital Management LLC	34,000	$440K	0.0%	-46.9%	0.030%
2/17/2026	Schonfeld Strategic Advisors LLC	144,728	$1.87M	0.0%	+364.9%	0.129%
2/17/2026	PDT Partners LLC	22,252	$288K	0.0%	N/A	0.020%
2/17/2026	AQR Capital Management LLC	414,742	$5.36M	0.0%	+110.7%	0.370%
2/17/2026	Amundi	39,676	$513K	0.0%	+11.0%	0.035%
2/17/2026	Jump Financial LLC	561,237	$7.26M	0.1%	+159.3%	0.501%
2/17/2026	Price T Rowe Associates Inc. MD	94,094	$1.22M	0.0%	-14.7%	0.084%
2/17/2026	T. Rowe Price Investment Management Inc.	3,143	$41K	0.0%	-99.7%	0.003%
2/17/2026	California State Teachers Retirement System	99,304	$1.28M	0.0%	-4.7%	0.089%
2/17/2026	Russell Investments Group Ltd.	155,199	$2.01M	0.0%	-95.5%	0.139%
2/17/2026	Captrust Financial Advisors	10,646	$138K	0.0%	N/A	0.010%
2/17/2026	Royal Bank of Canada	12,830	$166K	0.0%	+14.9%	0.011%
2/17/2026	Graham Capital Management L.P.	38,857	$502K	0.0%	+284.9%	0.035%
2/16/2026	Squarepoint Ops LLC	53,045	$686K	0.0%	-35.4%	0.047%
2/16/2026	Verition Fund Management LLC	168,873	$2.18M	0.0%	-94.5%	0.151%
2/16/2026	Walleye Trading LLC	25,808	$334K	0.0%	N/A	0.023%
2/16/2026	Mariner LLC	20,368	$264K	0.0%	-13.5%	0.018%
2/16/2026	Healthcare of Ontario Pension Plan Trust Fund	927,400	$11.99M	0.0%	N/A	0.828%
2/16/2026	Arax Advisory Partners	21,933	$284K	0.0%	-36.9%	0.020%
2/16/2026	Barclays PLC	447,255	$5.78M	0.0%	+12.4%	0.399%
2/13/2026	Kestra Advisory Services LLC	3,763	$49K	0.0%	N/A	0.003%
2/13/2026	The Manufacturers Life Insurance Company	41,303	$534K	0.0%	-3.9%	0.037%
2/13/2026	Walleye Capital LLC	11,676	$151K	0.0%	-94.6%	0.010%
2/13/2026	Morgan Stanley	5,069,895	$65.55M	0.0%	+453.4%	4.528%
2/13/2026	Schroder Investment Management Group	1,019,969	$13.48M	0.0%	+129.3%	0.911%
2/13/2026	Jacobs Levy Equity Management Inc.	1,223,755	$15.82M	0.1%	+1,093.2%	1.093%
2/13/2026	Headlands Technologies LLC	23,700	$306K	0.0%	-55.2%	0.021%
2/13/2026	Birchview Capital LP	152,100	$1.97M	1.2%	+49.0%	0.136%
2/13/2026	Charles Schwab Investment Management Inc.	876,816	$11.34M	0.0%	-3.7%	0.783%
2/13/2026	State Street Corp	2,577,239	$33.32M	0.0%	-81.3%	2.302%
2/13/2026	Ieq Capital LLC	378,974	$4.90M	0.0%	+568.6%	0.338%
2/13/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	226,500	$2.93M	0.0%	-81.1%	0.202%
2/12/2026	Soleus Capital Management L.P.	8,530,665	$110.30M	4.1%	-11.6%	7.618%
2/12/2026	Hohimer Wealth Management LLC	23,250	$301K	0.0%	-69.6%	0.021%
It’s not about Greenland (Ad) The petrodollar arrangement that anchored the US dollar for 50 years quietly expired in June 2024. Since then, China has cut its Treasury holdings by 45% from their peak, and BRICS nations offloaded $47 billion of American debt in a single month. The Trump administration has responded with a $12 billion critical minerals stockpile called Project Vault, equity stakes in miners like MP Materials and Lithium Americas, and a push to secure resources from Greenland to Ukraine. Porter Stansberry lays out the full story in a new documentary, including five companies positioned at the chokepoints of what he calls Trump's New Dollar. Watch the full documentary before December's economic summit in Miami
2/12/2026	HRT Financial LP	250,862	$3.24M	0.0%	-31.0%	0.224%
2/12/2026	MetLife Investment Management LLC	56,930	$736K	0.0%	-9.2%	0.051%
2/12/2026	Renaissance Technologies LLC	1,387,754	$17.94M	0.0%	+29.4%	1.239%
2/12/2026	Dimensional Fund Advisors LP	752,143	$9.73M	0.0%	+32.9%	0.672%
2/12/2026	Counterpoint Mutual Funds LLC	38,605	$499K	0.0%	+23.1%	0.034%
2/12/2026	Federated Hermes Inc.	115,136	$1.49M	0.0%	+9.2%	0.103%
2/12/2026	Ensign Peak Advisors Inc	6,737	$87K	0.0%	-76.0%	0.006%
2/12/2026	Campbell & CO Investment Adviser LLC	49,367	$638K	0.0%	+65.9%	0.044%
2/12/2026	Swiss National Bank	209,500	$2.71M	0.0%	+2.0%	0.187%
2/12/2026	Nuveen LLC	1,273,349	$16.46M	0.0%	-25.4%	1.137%

NVCR Institutional Ownership - Frequently Asked Questions

During the previous two years, 233 institutional investors and hedge funds held shares of NovoCure. The most heavily invested institutionals were FMR LLC ($483.66M), Capital International Investors ($264.44M), Vanguard Group Inc. ($141.69M), Soleus Capital Management L.P. ($110.30M), Morgan Stanley ($65.55M), State Street Corp ($33.32M), and Geode Capital Management LLC ($32.03M).Learn more on NovoCure's institutional investors.

84.61% of NovoCure's stock is owned by institutional investors. Learn more on NVCR's institutional investor holdings.

Of the 197 institutional investors that purchased NovoCure's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Morgan Stanley ($4.15M), Soleus Capital Management L.P. ($4.12M), California State Teachers Retirement System ($1.68M), Nordwand Advisors LLC ($1.51M), SG Americas Securities LLC ($1.28M), American Century Companies Inc. ($1.22M), and UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ($1.17M).

Institutional investors have bought a total of 20,807,535 shares in the last 24 months. This purchase volume represents approximately $268.34M in transactions.

Of the 67 institutional investors that sold NovoCure's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Voya Investment Management LLC ($64.54M), State Street Corp ($11.21M), BNP Paribas Financial Markets ($10.96M), Capital World Investors ($4.38M), Russell Investments Group Ltd. ($3.28M), Verition Fund Management LLC ($2.93M), and T. Rowe Price Investment Management Inc. ($1.88M).

Institutional investors have sold a total of 106,310,336 shares in the last 24 months. This volume of shares sold represents approximately $1.37B in transactions.

Related Companies

Institutional ownership data for NASDAQ:NVCR is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/27/2026. New 13F filings are added each quarter as they're published.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NovoCure (NVCR) Institutional Ownership

NVCR Institutional Buying and Selling by Quarter

NovoCure Major Shareholders & Ownership History

NVCR Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

NovoCure (NVCR) Institutional Ownership

Institutional Ownership Changes (13F Filings) for NovoCure (NASDAQ:NVCR)

NVCR Institutional Buying and Selling by Quarter

NovoCure Major Shareholders & Ownership History

NVCR Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of NVCR shares?

What percentage of NovoCure's stock is owned by institutional investors?

Which institutional investors have been buying NovoCure's stock?

How much institutional buying is happening at NovoCure?

Which of NovoCure's major shareholders have been selling company stock?

How much institutional selling is happening at NovoCure?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools